Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT01275586
What this trial is testing

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Who this might be right for
NeurofibromatosisNF1Neurofibromas
Indiana University 6
Testing effectiveness (Phase 2)Study completedNCT01207687
What this trial is testing

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
National Cancer Institute (NCI) 14
Post-approval studies (Phase 4)Looking for participantsNCT04460521
What this trial is testing

The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome

Who this might be right for
Carpal Tunnel SyndromeHand Injuries and DisordersNerve Compression+3 more
Emily Krauss 240
Large-scale testing (Phase 3)Study completedNCT00002898
What this trial is testing

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
Societe Internationale d'Oncologie Pediatrique 400
Large-scale testing (Phase 3)Study completedNCT00002944
What this trial is testing

Combination Chemotherapy in Treating Children With Progressive Brain Tumors

Who this might be right for
Brain TumorsCentral Nervous System Tumors
Children's Oncology Group 428
Early research (Phase 1)Study completedNCT02444884
What this trial is testing

MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Excluding CNSNeuroblastoma
Children's Oncology Group 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT03786783
What this trial is testing

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaHigh Risk Neuroblastoma
National Cancer Institute (NCI) 42
Large-scale testing (Phase 3)Not Yet RecruitingNCT07504198
What this trial is testing

Neuroprotection of Memantine and Rosuvastatin

Who this might be right for
Peripheral Nerve Disease
Tanta University 46
Testing effectiveness (Phase 2)Study completedNCT00006233
What this trial is testing

Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT04495127
What this trial is testing

Selumetinib Paediatric NF1 Japan Study

Who this might be right for
Neurofibromatosis Type 1
AstraZeneca 12
Not applicableAvailableNCT05028166
What this trial is testing

Individual Patient Compassionate Use of Mirdametinib

Who this might be right for
Neurofibromatosis Type 1-Associated Plexiform NeurofibromasHistiocytic NeoplasmOther MAP-K Pathway Driven Diseases
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Post-approval studies (Phase 4)WithdrawnNCT02379754
What this trial is testing

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Who this might be right for
Vestibular Schwannoma
Lund University
Not applicableStudy completedNCT05196854
What this trial is testing

Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1

Who this might be right for
HypertensionNeurofibromatosis 1Blood Pressure
Murdoch Childrens Research Institute 54
Not applicableUnknownNCT00900211
What this trial is testing

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX

Who this might be right for
Sarcoma
The Christie NHS Foundation Trust 400
Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Not applicableStudy completedNCT01222728
What this trial is testing

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

Who this might be right for
NeoplasmsNervous System DiseaseVestibular Disease
National Institute of Neurological Disorders and Stroke (NINDS) 5
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Not applicableStudy completedNCT01418495
What this trial is testing

Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma

Who this might be right for
Localized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaNeurotoxicity Syndrome+4 more
National Cancer Institute (NCI) 12
Not applicableAvailableNCT01370330
What this trial is testing

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

Who this might be right for
Neuroblastoma
Kieuhoa Vo
Next Page